Skip to content
Disclosery

BOONE CAPITAL MANAGEMENT LLC

Follow

13F filer, CIK 1882053, ATLANTA, GA

BOONE CAPITAL MANAGEMENT LLC reported $233,185,246 across 11 holdings for the quarter ended 2025-06-30, in a 13F-HR filed 2025-08-14. Its ten largest share positions make up 96.94% of the portfolio.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001214659-25-012210

Period
2025-06-30
Reported value
$233M
Holdings
11
Top 10 weight
96.94%
New
5
Sold out
6

Largest buys vs the previous quarter

SecurityShares changeApprox. value
AVTRnew+1,694,482$22.8M
NBIXnew+180,338$22.7M
UNHnew+58,112$18.1M
ICLRnew+95,832$13.9M
ABEOnew+1,254,658$7.13M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
UNMreduced-418,810-$33.8M
GMEDexited-360,764-$26.4M
MOHexited-67,555-$22.3M
PRGOexited-704,824-$19.8M
ISRGexited-38,930-$19.3M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q2 2025

Share positions as resolved from 13F-HR 0001214659-25-012210, largest first. % of portfolio is the value over $233,185,246, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
MDTMEDTRONIC PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 393,737 shares; 2025Q2: 428,789 shares 428,789$37.4M16.03%+35,052Timeline
MIRMMIRUM PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 543,843 shares; 2024Q4: 581,843 shares; 2025Q1: 603,318 shares; 2025Q2: 641,448 shares 641,448$32.6M14%+38,130Timeline
BMRNBIOMARIN PHARMACEUTICAL INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 327,279 shares; 2025Q2: 447,449 shares 447,449$24.6M10.55%+120,170Timeline
AVTRAVANTOR INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 1,694,482 shares 1,694,482$22.8M9.78%newTimeline
UNMUNUM GROUPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 964,170 shares; 2024Q4: 803,865 shares; 2025Q1: 700,600 shares; 2025Q2: 281,790 shares 281,790$22.8M9.76%-418,810Timeline
NBIXNEUROCRINE BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 180,338 shares 180,338$22.7M9.72%newTimeline
PNTGPENNANT GROUP INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 641,255 shares; 2024Q4: 641,255 shares; 2025Q1: 719,137 shares; 2025Q2: 649,022 shares 649,022$19.4M8.31%-70,115Timeline
UNHUNITEDHEALTH GROUP INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 58,112 shares 58,112$18.1M7.77%newTimeline
ICLRICON PUB LTD COQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 95,832 shares 95,832$13.9M5.98%newTimeline
CITHE CIGNA GROUPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 131,926 shares; 2024Q4: 85,861 shares; 2025Q1: 70,859 shares; 2025Q2: 35,600 shares 35,600$11.8M5.05%-35,259Timeline
ABEOABEONA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 1,254,658 shares 1,254,658$7.13M3.06%newTimeline

Sold out in Q2 2025

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
GMEDGLOBUS MED INC360,764$26.4Mshares
MOHMOLINA HEALTHCARE INC67,555$22.3Mshares
PRGOPERRIGO CO PLC704,824$19.8Mshares
ISRGINTUITIVE SURGICAL INC38,930$19.3Mshares
OFIXORTHOFIX MED INC948,202$15.5Mshares
BHVNBIOHAVEN LTD270,198$6.5Mshares

How Q2 2025 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001214659-25-012210 base2025-08-14acceptance time not in the bulk data set